Holen Sie sich die Stockscreener-App
1.1319
2.91%
-0.0381
Finanzdaten der Fate Therapeutics Inc-Aktie (FATE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
21.37%
1.369
|
1.741 | 1.907 | 1.629 | 1.86 |
Operating Expenses
|
1.06%
36.09
|
36.48 | 38.88 | 42.91 | 63.61 |
| Benefits Costs and Expenses |
-109.22
|
- | - | 39.25 | 54.01 |
| Costs And Expenses |
23.73%
45.13
|
36.48 | 38.88 | 39.25 | 54.01 |
| Operating Income/Loss |
0.04%
-34.72
|
-34.73 | -36.97 | -41.28 | -61.75 |
| Income/Loss From Continuing Operations Before Tax |
6,252%
110.59
|
1.741 | -34.07 | -37.62 | -52.15 |
| Income/Loss From Continuing Operations After Tax |
0.38%
-32.37
|
-32.25 | -34.07 | -37.62 | -52.15 |
|
Net Income/Loss
|
0.38%
-32.37
|
-32.25 | -34.07 | -37.62 | -52.15 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.87%
0.1536
|
119.00 | 118.53 | 118.38 | 1.3797 |
| Diluted Average Shares |
99.87%
0.1536
|
119.00 | 118.53 | 118.38 | 1.3797 |
| Basic Earnings Per Share |
0.00%
-0.27
|
-0.27 | -0.29 | -0.32 | -0.45 |
| Diluted Earnings Per Share |
0.00%
-0.27
|
-0.27 | -0.29 | -0.32 | -0.45 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):